Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-014182
Filing Date
2021-03-31
Accepted
2021-03-31 16:30:18
Documents
2
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1592
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3899
  Complete submission text file 0000899243-21-014182.txt   6971
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 235 SW CHURCH ST. PULLMAN WA 99163
Business Address
Schwartz Elissa J. (Reporting) CIK: 0001827177 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 21793825